TY - JOUR
T1 - The modifying effect of mutant LRRK2 on mutant GBA1-associated Parkinson disease
AU - Serebryany-Piavsky, Vera
AU - Egulsky, Lian
AU - Manoim-Wolkovitz, Julia Elia
AU - Anis, Saar
AU - Hassin-Baer, Sharon
AU - Parnas, Moshe
AU - Horowitz, Mia
N1 - Publisher Copyright:
© 2025 The Author(s).
PY - 2025/7/15
Y1 - 2025/7/15
N2 - Parkinson disease (PD) is the second most common neurodegenerative disease. While most cases are sporadic, in ∼ 5%-10% of PD patients the disease is caused by mutations in several genes, among them GBA1 (glucocerebrosidase beta 1) and LRRK2 (leucine-rich repeat kinase 2), both prevalent among the Ashkenazi Jewish population. LRRK2-associated PD tends to be milder than GBA1-associated PD. Several recent clinical studies have suggested that carriers of both GBA1 and LRRK2 mutations develop milder PD compared to that observed among GBA1 carriers. These findings strongly suggested an interplay between the two genes in the development and progression of PD. In the present study Drosophila was employed as a model to investigate the impact of mutations in the LRRK2 gene on mutant GBA1-associated PD. Our results strongly indicated that flies expressing both mutant genes exhibited milder parkinsonian signs compared to the disease developed in flies expressing only a GBA1 mutation. This was corroborated by a decrease in the ER stress response, increase in the number of dopaminergic cells, elevated levels of tyrosine hydroxylase, reduced neuroinflammation, improved locomotion and extended survival. Furthermore, a significant decrease in the steady-state levels of mutant GBA1-encoded GCase was observed in the presence of mutant LRRK2, strongly implying a role for mutant LRRK2 in degradation of mutant GCase.
AB - Parkinson disease (PD) is the second most common neurodegenerative disease. While most cases are sporadic, in ∼ 5%-10% of PD patients the disease is caused by mutations in several genes, among them GBA1 (glucocerebrosidase beta 1) and LRRK2 (leucine-rich repeat kinase 2), both prevalent among the Ashkenazi Jewish population. LRRK2-associated PD tends to be milder than GBA1-associated PD. Several recent clinical studies have suggested that carriers of both GBA1 and LRRK2 mutations develop milder PD compared to that observed among GBA1 carriers. These findings strongly suggested an interplay between the two genes in the development and progression of PD. In the present study Drosophila was employed as a model to investigate the impact of mutations in the LRRK2 gene on mutant GBA1-associated PD. Our results strongly indicated that flies expressing both mutant genes exhibited milder parkinsonian signs compared to the disease developed in flies expressing only a GBA1 mutation. This was corroborated by a decrease in the ER stress response, increase in the number of dopaminergic cells, elevated levels of tyrosine hydroxylase, reduced neuroinflammation, improved locomotion and extended survival. Furthermore, a significant decrease in the steady-state levels of mutant GBA1-encoded GCase was observed in the presence of mutant LRRK2, strongly implying a role for mutant LRRK2 in degradation of mutant GCase.
KW - Drosophila
KW - GBA1
KW - LRRK2
KW - Parkinson disease
UR - https://www.scopus.com/pages/publications/105010729651
U2 - 10.1093/hmg/ddaf062
DO - 10.1093/hmg/ddaf062
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 40315377
AN - SCOPUS:105010729651
SN - 0964-6906
VL - 34
SP - 1184
EP - 1203
JO - Human Molecular Genetics
JF - Human Molecular Genetics
IS - 14
ER -